EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of MDM2‐Targeting PROTAC for Advancing Bone Regeneration

Sol Jeong iD, Jae-Kook Cha iD, Wasim Ahmed iD, Jaewan Kim, Minsup Kim iD, Kyung Tae Hong, Wonji Choi, Sunjoo Choi iD, Tae Hyeon Yoo iD, Hyun-Ju An iD, Seung Chan An, Jaemin Lee und 6 weitere

Advanced Science · 2025-05 · 12 (19)

DOI: 10.1002/advs.202415626 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.03.2025. Verfasst von Sol Jeong und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Microbiology and Immunology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 08826, Republic …. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-mdm2, Bone Regeneration. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Government, National Research Council of Science & Technology, Korea Government, Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis‐targeting chimeras (PROTACs) degrade target proteins through the ubiquitin‐proteasome system. To date, PROTACs are primarily used to treat various diseases; however, they have not been applied in regenerative therapy. Herein, this work introduces MDM2‐targeting PROTACs customized for application in bone regeneration. An MDM2‐PROTAC library is constructed by combining Nutlin‐3 and CRBN ligands with various linker designs. Through a multistep validation process, this work develops MDM2‐PROTACs (CL144 and CL174) that presented potent degradation efficiency and a robust inductive effect on the biomineralization. Next, this work performs whole‐transcriptome analysis to dissect the biological effects of the CL144, and reveals the upregulation of osteogenic marker genes. Furthermore, CL144 effectively induced bone regeneration in bone graft and ovariectomy (OVX) models after local and systemic administration, respectively. In the OVX model, the combination treatment with CL144 and alendronate induced a synergistic effect. Overall, this study demonstrates the promising role of MDM2‐PROTAC in promoting bone regeneration, marking the first step toward expanding the application of the PROTAC technology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-mdm2Bone RegenerationAnimalsMiceFemaleProteolysisHumansOsteogenesisImidazolesPiperazines

Stichwörter der Autor:innen

MDM2PROTACboneosteoporosisregenerative medicine

Substanzen

Proto-Oncogene Proteins c-mdm2Imidazolesnutlin 3Piperazines

Autor:innen und Institutionen

  • Department of Oral Microbiology and Immunology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul, 08826, Republic of Korea.
  • Department of Periodontology, Research Institute of Periodontal Regeneration, College of Dentistry, Yonsei University, Seoul, 03722, Republic of Korea.
  • Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, 02115, USA.
  • Department of Molecular Science and Technology, Ajou University, Gyeonggi-do, 16499, Republic of Korea.
  • TARS Scientific, Seoul, 01717, Republic of Korea.
  • Department of Pharmacology, Korea University College of Medicine, Korea University, Seoul, 02841, Republic of Korea.

ORCID-Profile: Sol Jeong, Jae-Kook Cha, Wasim Ahmed, Minsup Kim, Sunjoo Choi, Tae Hyeon Yoo, Hyun-Ju An, Sun-Young Kim, Jun-Seok Lee, Junwon Choi, Jin Man Kim

Förderung

  • National Research Foundation of Korea, Korea Government
  • National Research Council of Science & Technology, Korea Government
  • Ministry of Health & Welfare, Republic of Korea
  • Ajou University

Zitieren

APA

Jeong, S., Cha, J. K., Ahmed, W., Kim, J., Kim, M., Hong, K. T., Choi, W., Choi, S., Yoo, T. H., An, H. J., An, S. C., Lee, J., Choi, J., Kim, S. Y., Lee, J. S., Lee, S., Choi, J., & Kim, J. M. (2025). Development of MDM2‐Targeting PROTAC for Advancing Bone Regeneration. Advanced Science, 12(19). https://doi.org/10.1002/advs.202415626

Vancouver

Jeong S, Cha JK, Ahmed W, Kim J, Kim M, Hong KT, et al. Development of MDM2‐Targeting PROTAC for Advancing Bone Regeneration. Advanced Science. 2025;12(19). doi:10.1002/advs.202415626

BibTeX
@article{Jeong2025,
  author = {Jeong, Sol and Cha, Jae-Kook and Ahmed, Wasim and Kim, Jaewan and Kim, Minsup and Hong, Kyung Tae and Choi, Wonji and Choi, Sunjoo and Yoo, Tae Hyeon and An, Hyun-Ju and An, Seung Chan and Lee, Jaemin and Choi, Jimin and Kim, Sun-Young and Lee, Jun-Seok and Lee, Soonchul and Choi, Junwon and Kim, Jin Man},
  title = {Development of MDM2‐Targeting PROTAC for Advancing Bone Regeneration},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {19},
  doi = {10.1002/advs.202415626}
}
Kostenlos starten →